Compass Pathways
UK - CheshireBiotechnology
Focus: Compass Pathways is a UK-based biotechnology company focused on psilocybin-assisted therapy for psychiatric disorders, operating in the emerging psychedelic medicine space. The company is advancing a clinical-stage pipeline targeting treatment-resistant depression, major depressive disorder, and other psychiatric indications.
Profile data last refreshed 2h ago · AI intelligence enriched 1w ago
Open Jobs
35-2 this month
Stable — net -2 jobs in 30d
16 added, 18 removed. Backfill posture.
Should You Work at Compass Pathways?
AI assessmentBest suited for risk-tolerant professionals seeking ground-floor exposure to a novel therapeutic modality with clear near-term clinical catalysts but substantial regulatory and market adoption uncertainty.
Why Work Here
- Opportunity to join a pioneering company in the psychedelic medicine sector with potential to reshape psychiatric treatment paradigms
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)
Treatment Resistant DepressionClinical Trials (1)
NCT04519957Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)
N/AHelp build intelligence for Compass Pathways
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.